NYSE:STE - Steris Stock Price, Price Target & More

Steris trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

Steris declared a quarterly dividend on Friday, May 11th. Investors of record on Friday, June 8th will be given a dividend of $0.31 per share on Thursday, June 28th. This represents a $1.24 dividend on an annualized basis and a yield of 1.12%. The ex-dividend date is Thursday, June 7th. View Steris' Dividend History.

Steris PLC (NYSE:STE) issued its quarterly earnings results on Wednesday, May, 9th. The medical equipment provider reported $1.24 earnings per share for the quarter, beating analysts' consensus estimates of $1.22 by $0.02. The medical equipment provider had revenue of $716 million for the quarter, compared to the consensus estimate of $703.37 million. Steris had a net margin of 11.10% and a return on equity of 11.55%. Steris's quarterly revenue was up 5.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS. View Steris' Earnings History.

Steris is scheduled to release their next quarterly earnings announcement on Tuesday, August, 14th 2018. View Earnings Estimates for Steris.

Steris issued an update on its FY19 earnings guidance on Wednesday, May, 9th. The company provided earnings per share (EPS) guidance of $4.63-$4.75 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.69.

4 brokers have issued twelve-month price targets for Steris' shares. Their predictions range from $16.00 to $103.00. On average, they anticipate Steris' share price to reach $80.25 in the next twelve months. This suggests that the stock has a possible downside of 27.3%. View Analyst Ratings for Steris.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Steris in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Some companies that are related to Steris include Edwards Lifesciences (EW), Align Technology (ALGN), Zimmer Biomet (ZBH), COLOPLAST A/S/ADR (CLPBY), Smith & Nephew (SNN), WILLIAM DEMANT/ADR (WILYY), Inogen (INGN), MSA Safety (MSA), Wright Medical Group (WMGI), Halyard Health (HYH), CONSORT Med PLC/S (CSRMY), Invacare (IVC), Sientra (SIEN), RTI Surgical (RTIX) and Lakeland Industries (LAKE).

Media stories about STE stock have been trending somewhat positive on Sunday, Accern Sentiment Analysis reports. The research group rates the sentiment of press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Steris earned a media sentiment score of 0.07 on Accern's scale. They also assigned news headlines about the medical equipment provider an impact score of 47.53 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.

Steris' stock is owned by many different of retail and institutional investors. Top institutional shareholders include Fisher Asset Management LLC (1.70%), Addenda Capital Inc. (0.02%), Addenda Capital Inc. (0.01%), State of Alaska Department of Revenue (0.01%), Private Trust Co. NA (0.01%) and Clinton Group Inc. (0.00%). Company insiders that own Steris stock include Adrian Vincent Coward, Cynthia L Feldmann, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Kathleen Bardwell, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Richard Martin Steeves, Sudhir K Pahwa, Walter M Rosebrough Jr and Walter M Rosebrough, Jr. View Institutional Ownership Trends for Steris.

STE stock was sold by a variety of institutional investors in the last quarter, including Fisher Asset Management LLC and Private Trust Co. NA. Company insiders that have sold Steris company stock in the last year include Cynthia L Feldmann, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Richard Martin Steeves, Sudhir K Pahwa and Walter M Rosebrough Jr. View Insider Buying and Selling for Steris.

STE stock was acquired by a variety of institutional investors in the last quarter, including Addenda Capital Inc., Clinton Group Inc., State of Alaska Department of Revenue, Empirical Finance LLC and Addenda Capital Inc.. View Insider Buying and Selling for Steris.

Shares of STE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of STE stock can currently be purchased for approximately $110.38.

Steris has a market capitalization of $9.34 billion and generates $2.62 billion in revenue each year. The medical equipment provider earns $290.91 million in net income (profit) each year or $4.15 on an earnings per share basis. Steris employs 12,000 workers across the globe.

Steris' mailing address is Rutherford House Stephensons Way Chaddesden, Derby X0, DE21 6LY. The medical equipment provider can be reached via phone at 44-13-3238-7100 or via email at [email protected]